Geneos Wealth Management’s BondBloxx Bloomberg One Year Target Duration US Treasury ETF XONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,946
Closed -$96.4K 2541
2026
Q1
$96.4K Sell
1,946
-257
-12% -$12.7K ﹤0.01% 1185
2025
Q4
$109K Sell
2,203
-257
-10% -$12.7K ﹤0.01% 1127
2025
Q3
$122K Sell
2,460
-929
-27% -$46K ﹤0.01% 1059
2025
Q2
$168K Sell
3,389
-593
-15% -$29.4K ﹤0.01% 1058
2025
Q1
$198K Buy
3,982
+609
+18% +$30.2K 0.01% 913
2024
Q4
$167K Buy
+3,373
New +$167K 0.01% 899

Other funds holding XONE

Geneos Wealth Management's XONE Position: Q2 2026 in Review

Geneos Wealth Management sold out of BondBloxx Bloomberg One Year Target Duration US Treasury ETF (XONE) in Q2 2026, closing a stake of 1,946 shares — an estimated $96.4K sold.

Geneos Wealth Management first reported a position in XONE in Q4 2024 and held it in 6 quarters. The position peaked at $198K in Q1 2025. 101 funds tracked by Wall St. Rank hold XONE as of Q2 2026.

  • Geneos Wealth Management reported no remaining BondBloxx Bloomberg One Year Target Duration US Treasury ETF position as of Q2 2026 after selling out during the quarter.
  • Geneos Wealth Management sold 1,946 BondBloxx Bloomberg One Year Target Duration US Treasury ETF shares in Q2 2026, an estimated $96.4K.
  • Geneos Wealth Management first reported a position in BondBloxx Bloomberg One Year Target Duration US Treasury ETF in Q4 2024 and held it in 6 quarters.
  • Geneos Wealth Management's BondBloxx Bloomberg One Year Target Duration US Treasury ETF position peaked at $198K in Q1 2025.
  • 101 funds tracked by Wall St. Rank held BondBloxx Bloomberg One Year Target Duration US Treasury ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.